New drug trial aims to shield transplant patients from deadly fungal infections
Prevention
ENROLLING_BY_INVITATION
This study is testing whether a new antifungal drug called rezafungin can prevent serious fungal infections in liver transplant patients who are at high risk. About 385 patients will receive either rezafungin or standard antifungal medications, and researchers will compare infect…
Phase: PHASE3 • Sponsor: Fernanda P Silveira, MD, MS • Aim: Prevention
Last updated Mar 31, 2026 12:12 UTC